CADENCE PHARMACEUTICALS INC 4
4 · CADENCE PHARMACEUTICALS INC · Filed Mar 21, 2014
Insider Transaction Report
Form 4
DOMAIN ASSOCIATES
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2014-03-19$14.00/sh−27,500$385,000→ 0 total
Footnotes (1)
- [F1]In connection with the acquisition of the Issuer by Mallinckrodt plc ("Parent") on March 19, 2014, and pursuant to the terms of the Agreement and Plan of Merger by and among the Issuer, Parent and Madison Merger Sub, Inc. ("Merger Sub") dated February 10, 2014, Merger Sub acquired all of the issued and outstanding shares of Common Stock (the "Shares") for a purchase price of $14.00 per Share.